# Evaluation of Cilostazol in Combination With L-Carnitine

> **NCT00822172** · PHASE4 · COMPLETED · sponsor: **Colorado Prevention Center** · enrollment: 164 (actual)

## Conditions studied

- Peripheral Vascular Disease
- Intermittent Claudication
- Peripheral Arterial Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Levocarnitine tartrate
- **DRUG:** cilostazol

## Key facts

- **NCT ID:** NCT00822172
- **Lead sponsor:** Colorado Prevention Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-11
- **Final completion:** 2010-12
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2019-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00822172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00822172, "Evaluation of Cilostazol in Combination With L-Carnitine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00822172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*